Showing results (1091-1100 of 6,130) with videos related to

Sort By:
Pageof 613
International Journal of Antimicrobial Agents|December 24, 2014
Complexity of antimicrobial peptide regulation during pathogen-host interactionsGabriela M Wassing, Peter Bergman, Lennart Lindbom, et al.
International Journal of Antimicrobial Agents|December 24, 2014
Inhaled antibiotics beyond aminoglycosides, polymyxins and aztreonam: A systematic reviewMatthew E Falagas, Kyriakos K Trigkidis, Konstantinos Z Vardakas
International Journal of Antimicrobial Agents|December 4, 2014
Evaluation of in vitro synergy between vertilmicin and ceftazidime against Pseudomonas aeruginosa using a semi-mechanistic pharmacokinetic/pharmacodynamic modelLuning Zhuang, Sherwin K B Sy, Huiming Xia, et al.
International Journal of Antimicrobial Agents|October 13, 2014
Blood culture-guided de-escalation of empirical antimicrobial regimen for critical patients in an online antimicrobial stewardship programmeHsiu-Yin Wang, Cheng-Hsun Chiu, Ching-Tai Huang, et al.
International Journal of Antimicrobial Agents|January 14, 2020
Characterisation and risk factor profiling of Pseudomonas aeruginosa urinary tract infections: pinpointing those likely to be caused by multidrug-resistant strainsMario Tumbarello, Francesca Raffaelli, Maddalena Peghin, et al.
International Journal of Antimicrobial Agents|November 9, 2020
Post-exposure prophylaxis with hydroxychloroquine for the prevention of COVID-19, a myth or a reality? The PEP-CQ StudyDeba Prasad Dhibar, Navneet Arora, Arpit Kakkar, et al.
International Journal of Antimicrobial Agents|September 4, 2020
β-lactam dosing strategies: Think before you pushJiajun Liu, Nathaniel J Rhodes, Jason A Roberts, et al.
International Journal of Antimicrobial Agents|November 23, 2020
Comparison of dalbavancin to standard-of-care for outpatient treatment of invasive Gram-positive infectionsMichael P Veve, Nimish Patel, Zachary A Smith, et al.
International Journal of Antimicrobial Agents|November 15, 2020
Randomised controlled trials for COVID-19: evaluation of optimal randomisation methodologies-need for data validation of the completed trials and to improve ongoing and future randomised trial designsVenkata R Emani, Sanjeev Goswami, Dheeraj Nandanoor, et al.
International Journal of Antimicrobial Agents|November 10, 2019
Evaluation of super-boosted lopinavir/ritonavir in combination with rifampicin in HIV-1-infected patients with tuberculosisCatherine Boulanger, Valeria Rolla, Mohammad H Al-Shaer, et al.
Pageof 613